McKesson Current Ratio 2006-2019 | MCK

Current and historical current ratio for McKesson (MCK) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. McKesson current ratio for the three months ending September 30, 2019 was 1.01.
McKesson Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $37.35B $37.15B 1.01
2019-06-30 $38.43B $37.95B 1.01
2019-03-31 $38.47B $37.63B 1.02
2018-12-31 $38.32B $37.42B 1.02
2018-09-30 $38.54B $38.86B 0.99
2018-06-30 $38.21B $38.35B 1.00
2018-03-31 $37.14B $36.69B 1.01
2017-12-31 $40.20B $37.65B 1.07
2017-09-30 $39.79B $37.77B 1.05
2017-06-30 $37.70B $35.80B 1.05
2017-03-31 $36.95B $35.61B 1.04
2016-12-31 $39.27B $38.17B 1.03
2016-09-30 $41.34B $37.05B 1.12
2016-06-30 $39.04B $36.57B 1.07
2016-03-31 $38.44B $35.07B 1.10
2015-12-31 $38.26B $34.48B 1.11
2015-09-30 $38.75B $34.78B 1.11
2015-06-30 $38.57B $34.67B 1.11
2015-03-31 $36.67B $33.50B 1.10
2014-12-31 $37.14B $32.78B 1.13
2014-09-30 $33.88B $29.34B 1.16
2014-06-30 $33.97B $29.25B 1.16
2014-03-31 $32.84B $29.62B 1.11
2013-12-31 $25.23B $21.90B 1.15
2013-09-30 $24.55B $21.38B 1.15
2013-06-30 $24.07B $21.48B 1.12
2013-03-31 $23.17B $21.36B 1.09
2012-12-31 $23.44B $20.21B 1.16
2012-09-30 $23.09B $20.75B 1.11
2012-06-30 $22.05B $20.10B 1.10
2012-03-31 $23.60B $21.69B 1.09
2011-12-31 $24.57B $20.72B 1.19
2011-09-30 $23.26B $19.85B 1.17
2011-06-30 $22.37B $19.14B 1.17
2011-03-31 $22.36B $18.73B 1.19
2010-12-31 $21.69B $19.69B 1.10
2010-09-30 $20.24B $16.39B 1.24
2010-06-30 $20.79B $16.89B 1.23
2010-03-31 $21.50B $17.01B 1.26
2009-12-31 $20.85B $16.92B 1.23
2009-09-30 $19.93B $16.42B 1.21
2009-06-30 $19.06B $15.94B 1.20
2009-03-31 $18.67B $15.61B 1.20
2008-12-31 $18.37B $16.06B 1.14
2008-09-30 $17.54B $15.15B 1.16
2008-06-30 $17.93B $15.62B 1.15
2008-03-31 $17.79B $15.35B 1.16
2007-12-31 $18.68B $15.85B 1.18
2007-09-30 $18.79B $15.61B 1.20
2007-06-30 $18.16B $14.86B 1.22
2007-03-31 $17.86B $15.13B 1.18
2006-12-31 $18.30B $14.73B 1.24
2006-09-30 $17.30B $13.93B 1.24
2006-06-30 $17.11B $13.83B 1.24
2006-03-31 $17.00B $13.47B 1.26
2005-12-31 $16.93B $13.29B 1.27
2005-09-30 $16.69B $13.01B 1.28
2005-06-30 $15.75B $11.81B 1.33
2005-03-31 $15.36B $11.79B 1.30
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $27.500B $214.319B
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. McKesson partners with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by their ICARE shared principles, their employees work every day to innovate and deliver opportunities that make their customers and partners more successful - all for the better health of patients.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $75.255B 23.82
Align Technology (ALGN) United States $21.278B 58.31
AmerisourceBergen (ABC) United States $18.311B 12.56
Cooper (COO) United States $17.288B 28.53
Laboratory Of America Holdings (LH) United States $17.204B 16.15
Straumann Holding AG (SAUHF) Switzerland $16.456B 0.00
Cardinal Health (CAH) United States $15.742B 10.23
DENTSPLY SIRONA (XRAY) United States $13.269B 25.94
West Pharmaceutical Services (WST) United States $11.524B 49.44
Henry Schein (HSIC) United States $10.448B 19.45
CONMED (CNMD) United States $3.065B 43.55
Patterson (PDCO) United States $2.235B 16.56
Merit Medical Systems (MMSI) United States $2.020B 23.60
STAAR Surgical (STAA) United States $1.721B 89.86
Atrion (ATRI) United States $1.336B 36.79
Antares Pharma (ATRS) United States $0.650B 398.50
Invacare (IVC) United States $0.288B 0.00
Lifevantage (LFVN) United States $0.213B 23.46
Milestone Scientific (MLSS) United States $0.077B 0.00
Pro-Dex (PDEX) United States $0.067B 18.04
Retractable Technologies (RVP) United States $0.055B 83.50
Endologix (ELGX) United States $0.029B 0.00
Biolase (BIOL) United States $0.025B 0.00